Novabay Pharmaceuticals Inc盘中异动急速跳水6.94%报0.141美元

自选股智能写手02-15

北京时间2024年02月15日22时32分，Novabay Pharmaceuticals Inc（NBY.us）股票出现异动，股价大幅下挫6.94%。截至发稿，该股报0.141美元/股，成交量17.7608万股，换手率2.72%，振幅1.12%。最近的财报数据显示，该股实现营业收入3.27百万美元，净利润-1.76百万美元，每股收益-0.37美元，毛利1.84百万美元，市盈率-0.02倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2411549577?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-02-15 22:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2411549577","market":"us","top_or_hot":-1,"title":"Novabay Pharmaceuticals Inc盘中异动 急速跳水6.94%报0.141美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年02月15日22时32分，Novabay Pharmaceuticals Inc（NBY.us）股票出现异动，股价大幅下挫6.94%。截至发稿，该股报0.141美元/股，成交量17.7608万股，换手率2.72%，振幅1.12%。最近的财报数据显示，该股实现营业收入3.27百万美元，净利润-1.76百万美元，每股收益-0.37美元，毛利1.84百万美元，市盈率-0.02倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522323679119745&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novabay Pharmaceuticals Inc盘中异动 急速跳水6.94%报0.141美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovabay Pharmaceuticals Inc盘中异动 急速跳水6.94%报0.141美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-15 22:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522323679119745&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年02月15日22时32分，Novabay Pharmaceuticals Inc（NBY.us）股票出现异动，股价大幅下挫6.94%。截至发稿，该股报0.141美元/股，成交量17.7608万股，换手率2.72%，振幅1.12%。最近的财报数据显示，该股实现营业收入3.27百万美元，净利润-1.76百万美元，每股收益-0.37美元，毛利1.84百万美元，市盈率-0.02倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522323679119745&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522323679119745&s=b","article_id":"2411549577","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522323679119745&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2411549577","pubTimestamp":1708007556,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年02月15日22时32分，Novabay Pharmaceuticals Inc股票出现异动，股价大幅下挫6.94%。Novabay Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Coeptis Therapeutics Holdings Inc、Orgenesis Inc、Clene Inc C/Wts 30/12/2025 涨幅较大，Kintara Therapeutics Inc、Adial Pharmaceuticals Inc、Jaguar Health Inc较为活跃，换手率分别为24.98%、14.74%、11.68%，振幅较大的相关个股有Sol Gel Technologies Ltd、Adaptive Biotechnologies Corp、Promis Neurosciences Inc，振幅分别为16.67%、13.96%、11.85%。Novabay Pharmaceuticals Inc公司简介：NovaBay Pharmaceuticals Inc是一家生物制药公司，开发和销售科学创造并经过临床验证的眼部护理和护肤产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","NBY":"NovaBay Pharmaceuticals Inc"},"translate_title":"Novabay Pharmaceuticals Inc. plunged 6.94 percent to $0.141 in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBY":0.9},"content_text":"北京时间2024年02月15日22时32分，Novabay Pharmaceuticals Inc（NBY.us）股票出现异动，股价大幅下挫6.94%。截至发稿，该股报0.141美元/股，成交量17.7608万股，换手率2.72%，振幅1.12%。最近的财报数据显示，该股实现营业收入3.27百万美元，净利润-1.76百万美元，每股收益-0.37美元，毛利1.84百万美元，市盈率-0.02倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Novabay Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Coeptis Therapeutics Holdings Inc、Orgenesis Inc、Clene Inc C/Wts 30/12/2025 (To Pur Com)涨幅较大，Kintara Therapeutics Inc、Adial Pharmaceuticals Inc、Jaguar Health Inc较为活跃，换手率分别为24.98%、14.74%、11.68%，振幅较大的相关个股有Sol Gel Technologies Ltd、Adaptive Biotechnologies Corp、Promis Neurosciences Inc，振幅分别为16.67%、13.96%、11.85%。Novabay Pharmaceuticals Inc公司简介：NovaBay Pharmaceuticals Inc是一家生物制药公司，开发和销售科学创造并经过临床验证的眼部护理和护肤产品。其主导产品Avenova抗微生物眼睑和睫毛液(Avenova Spray)在实验室测试中被证明具有广泛的抗菌性能，因为它可以清除包括眼睑在内的眼部周围皮肤上的微生物和碎片等外来物质。Avenova Spray 可通过在线分销渠道直接向消费者提供，并且还经常由眼科护理专业人员开具处方和配药，用于治疗睑缘炎和干眼症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2411549577"}

Novabay Pharmaceuticals Inc盘中异动 急速跳水6.94%报0.141美元

精彩评论

Novabay Pharmaceuticals Inc盘中异动急速跳水6.94%报0.141美元